Skip to main content
. 2021 Sep 7;24(5):780. doi: 10.3892/mmr.2021.12420

Figure 1.

Figure 1.

Overexpressed ZSCAN16-AS1 indicates poor prognosis for patients with HCC. (A) ZSCAN16-AS1 expression in HCC was analyzed based on The Cancer Genome Atlas database. (B) The measurement of ZSCAN16-AS1 expression in HCC tissues was conducted applying reverse transcription-quantitative PCR. (C) Kaplan-Meier method was used to examine the relationship between ZSCAN16-AS1 expression and overall survival in patients with HCC. **P<0.01. HCC, hepatocellular carcinoma.